About Us


FlexPerc Medical (formerly phenoMapper) was founded in 2019 to advance minimally invasive cancer interventions by leveraging the strengths of AI and robotic technologies.


We started our journey with development of our patent-pending AI-based treatment planning software and ablation device for cancer interventions. We soon realized that positioning the tip of the ablation device accurately and consistently is paramount to the treatment success and adoption. With the advance development in intervention robotic system, we were able to bring in a robotic system with flexible delivery device capable of accurate and consistent device placement. The AI-based treatment planning software, flexible ablation device and intervention robotic system constitute the 1st full-stack flexible percutaneous intervention platform for cancer interventions.